Updates

Inspecs

February 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Last month’s NAP proved remarkably prescient when I said, “the shares would go like the clappers” after the next update - they certainly did. 42p at the time, they soared to 114p. As expected, SPEC had a difficult H2 due to lower sales in Germany but has seen an improving trend recently. At the same time, currency has reversed, costs have been taken out and there is headroom on its facilities. No changes to forecasts. After such a mercurial spike like this, you may wish to take a partial profit to leave a ‘free’ carry. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

XLMedia

Hercules Site Services - HS2 labour division growing explosively

Inspecs - Q1 signals the corner is turned (May 2024)

Inspecs (February 2024)

Inspecs - Margins enhanced by moving Eschenbach acetate manufacture to Vietnam (January 2024)

Inspecs (October 2023)

Inspecs (August 2023)

Inspecs - EBITDA forecast to jump US$6m this year (July 2023)

Inspecs (May 2023)

Inspecs - Interesting new issue (March 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X